Your browser doesn't support javascript.
The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.
Lim, K H J; Murali, K; Kamposioras, K; Punie, K; Oing, C; O'Connor, M; Thorne, E; Amaral, T; Garrido, P; Lambertini, M; Devnani, B; Westphalen, C B; Morgan, G; Haanen, J B A G; Hardy, C; Banerjee, S.
  • Lim KHJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Department of Immunology and Inflammation, Imperial College London, London, UK; Immunobiology Laboratory, The Francis Crick Institute, London, UK.
  • Murali K; Victorian Clinical Genetics Services, The Royal Children's Hospital, Melbourne, Australia.
  • Kamposioras K; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Punie K; Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Oing C; Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Mildred Scheel Cancer Career Centre HaTriCs4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • O'Connor M; University Hospital Waterford, Waterford, Ireland.
  • Thorne E; Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.
  • Amaral T; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany; Portuguese Air Force Health Care Direction, Lisbon, Portugal.
  • Garrido P; Medical Oncology, Hospital Ramón y Cajal, IRYCIS, Alcalá University, Madrid, Spain.
  • Lambertini M; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.
  • Devnani B; Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, Jodhpur, India.
  • Westphalen CB; Department of Internal Medicine III, University Hospital, LMU Munich and Comprehensive Cancer Center, Munich, Germany.
  • Morgan G; Department of Medical and Radiation Oncology, Skåne University Hospital, Lund, Sweden.
  • Haanen JBAG; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Hardy C; Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.
  • Banerjee S; Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK. Electronic address: susana.banerjee@rmh.nhs.uk.
ESMO Open ; 6(4): 100199, 2021 08.
Article in English | MEDLINE | ID: covidwho-1466337
ABSTRACT

BACKGROUND:

The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology.

METHODS:

This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measures including well-being/distress (expanded Well-being Index-9 items), burnout (1 item from expanded Well-being Index), and job performance since COVID-19 were tracked.

RESULTS:

A total of 942 participants from 99 countries were included for final

analysis:

58% (n = 544) from Europe, 52% (n = 485) female, 43% (n = 409) ≤40 years old, and 36% (n = 343) of non-white ethnicity. In July/August 2020, 60% (n = 525) continued to report a change in professional duties compared with the pre-COVID-19 era. The proportion of participants at risk of poor well-being (33%, n = 310) and who reported feeling burnout (49%, n = 460) had increased significantly compared with April/May 2020 (25% and 38%, respectively; P < 0.001), despite improved job performance since COVID-19 (34% versus 51%; P < 0.001). Of those who had been tested for COVID-19, 8% (n = 39/484) tested positive; 18% (n = 7/39) felt they had not been given adequate time to recover before return to work. Since the pandemic, 39% (n = 353/908) had expressed concerns that COVID-19 would have a negative impact on their career development or training and 40% (n = 366/917) felt that their job security had been compromised. More than two-thirds (n = 608/879) revealed that COVID-19 has changed their outlook on their work-personal life balance.

CONCLUSION:

The COVID-19 pandemic continues to impact the well-being of oncology professionals globally, with significantly more in distress and feeling burnout compared with the first wave. Collective efforts from both national and international communities addressing support and coping strategies will be crucial as we recover from the COVID-19 crisis. In particular, an action plan should also be devised to tackle concerns raised regarding the negative impact of COVID-19 on career development, training, and job security.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Burnout, Professional / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research Limits: Adult / Female / Humans Language: English Journal: ESMO Open Year: 2021 Document Type: Article Affiliation country: J.esmoop.2021.100199

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Burnout, Professional / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research Limits: Adult / Female / Humans Language: English Journal: ESMO Open Year: 2021 Document Type: Article Affiliation country: J.esmoop.2021.100199